| Symbol |
Name |
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACTN1
|
actinin, alpha 1
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
AFM
|
afamin
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGR2
|
anterior gradient 2
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHRR
|
aryl-hydrocarbon receptor repressor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AKAP13
|
A kinase (PRKA) anchor protein 13
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
AMH
|
anti-Mullerian hormone
|
|
AMHR2
|
anti-Mullerian hormone receptor, type II
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANXA1
|
annexin A1
|
|
ANXA4
|
annexin A4
|
|
APOE
|
apolipoprotein E
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ARNT
|
aryl hydrocarbon receptor nuclear translocator
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
AVP
|
arginine vasopressin
|
|
AXL
|
AXL receptor tyrosine kinase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BGN
|
biglycan
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BNC2
|
basonuclin 2
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BSG
|
basigin (Ok blood group)
|
|
C3
|
complement component 3
|
|
C5
|
complement component 5
|
|
C9
|
complement component 9
|
|
CALB1
|
calbindin 1, 28kDa
|
|
CALD1
|
caldesmon 1
|
|
CAPN5
|
calpain 5
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CAT
|
catalase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL25
|
chemokine (C-C motif) ligand 25
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CCR9
|
chemokine (C-C motif) receptor 9
|
|
CD1A
|
CD1a molecule
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD82
|
CD82 molecule
|
|
CD83
|
CD83 molecule
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental)
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B-AS1
|
CDKN2B antisense RNA 1
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFI
|
complement factor I
|
|
CFL1
|
cofilin 1 (non-muscle)
|
|
CHD5
|
chromodomain helicase DNA binding protein 5
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CLDN3
|
claudin 3
|
|
CLDN4
|
claudin 4
|
|
CLOCK
|
clock circadian regulator
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
CNTF
|
ciliary neurotrophic factor
|
|
COL18A1
|
collagen, type XVIII, alpha 1
|
|
COMT
|
catechol-O-methyltransferase
|
|
CRH
|
corticotropin releasing hormone
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL5
|
chemokine (C-X-C motif) ligand 5
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR6
|
chemokine (C-X-C motif) receptor 6
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYR61
|
cysteine-rich, angiogenic inducer, 61
|
|
DCN
|
decorin
|
|
DEFA1
|
defensin, alpha 1
|
|
DEFA3
|
defensin, alpha 3, neutrophil-specific
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DNMT3B
|
DNA (cytosine-5-)-methyltransferase 3 beta
|
|
DNMT3L
|
DNA (cytosine-5-)-methyltransferase 3-like
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DRD2
|
dopamine receptor D2
|
|
DUSP2
|
dual specificity phosphatase 2
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
EMX2
|
empty spiracles homeobox 2
|
|
EPO
|
erythropoietin
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERVW-1
|
endogenous retrovirus group W, member 1
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ESRRB
|
estrogen-related receptor beta
|
|
EZR
|
ezrin
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL3
|
Fc receptor-like 3
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOXP3
|
forkhead box P3
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FST
|
follistatin
|
|
GATA2
|
GATA binding protein 2
|
|
GATA6
|
GATA binding protein 6
|
|
GC
|
group-specific component (vitamin D binding protein)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDF9
|
growth differentiation factor 9
|
|
GH1
|
growth hormone 1
|
|
GHRH
|
growth hormone releasing hormone
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GPER1
|
G protein-coupled estrogen receptor 1
|
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
|
GREM1
|
gremlin 1, DAN family BMP antagonist
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGA2
|
high mobility group AT-hook 2
|
|
HNF1B
|
HNF1 homeobox B
|
|
HOXA10
|
homeobox A10
|
|
HOXA11
|
homeobox A11
|
|
HP
|
haptoglobin
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSD17B2
|
hydroxysteroid (17-beta) dehydrogenase 2
|
|
HSD17B7
|
hydroxysteroid (17-beta) dehydrogenase 7
|
|
HTRA1
|
HtrA serine peptidase 1
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNG
|
interferon, gamma
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGFBP1
|
insulin-like growth factor binding protein 1
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGFBP7
|
insulin-like growth factor binding protein 7
|
|
IHH
|
indian hedgehog
|
|
IL10
|
interleukin 10
|
|
IL11
|
interleukin 11
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL15
|
interleukin 15
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RAP
|
interleukin 1 receptor accessory protein
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL22
|
interleukin 22
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL33
|
interleukin 33
|
|
IL4
|
interleukin 4
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
IPO13
|
importin 13
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JUN
|
jun proto-oncogene
|
|
KCNQ2
|
potassium channel, voltage gated KQT-like subfamily Q, member 2
|
|
KDM1A
|
lysine (K)-specific demethylase 1A
|
|
KDR
|
kinase insert domain receptor
|
|
KIR2DS5
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 5
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KLF11
|
Kruppel-like factor 11
|
|
KLF9
|
Kruppel-like factor 9
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT19
|
keratin 19, type I
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMC2
|
laminin, gamma 2
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHB
|
luteinizing hormone beta polypeptide
|
|
LIF
|
leukemia inhibitory factor
|
|
LINCMD1
|
long intergenic non-protein coding RNA, muscle differentiation 1
|
|
LIPC
|
lipase, hepatic
|
|
LOXL1
|
lysyl oxidase-like 1
|
|
LOXL4
|
lysyl oxidase-like 4
|
|
LTA
|
lymphotoxin alpha
|
|
LTF
|
lactotransferrin
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MDK
|
midkine (neurite growth-promoting factor 2)
|
|
MEIS1
|
Meis homeobox 1
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR122
|
microRNA 122
|
|
MIR145
|
microRNA 145
|
|
MIR17
|
microRNA 17
|
|
MIR183
|
microRNA 183
|
|
MIR196B
|
microRNA 196b
|
|
MIR199A1
|
microRNA 199a-1
|
|
MIR20A
|
microRNA 20a
|
|
MIR22
|
microRNA 22
|
|
MIR23A
|
microRNA 23a
|
|
MIR23B
|
microRNA 23b
|
|
MIR520H
|
microRNA 520h
|
|
MIR542
|
microRNA 542
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MST1
|
macrophage stimulating 1
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC4
|
mucin 4, cell surface associated
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
NANOG
|
Nanog homeobox
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGF
|
nerve growth factor (beta polypeptide)
|
|
NGFR
|
nerve growth factor receptor
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NPY
|
neuropeptide Y
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRP1
|
neuropilin 1
|
|
NRP2
|
neuropilin 2
|
|
NTRK1
|
neurotrophic tyrosine kinase, receptor, type 1
|
|
NTRK2
|
neurotrophic tyrosine kinase, receptor, type 2
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
PAEP
|
progestagen-associated endometrial protein
|
|
PAK4
|
p21 protein (Cdc42/Rac)-activated kinase 4
|
|
PARK7
|
parkinson protein 7
|
|
PAX2
|
paired box 2
|
|
PDCD6
|
programmed cell death 6
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PEMT
|
phosphatidylethanolamine N-methyltransferase
|
|
PF4
|
platelet factor 4
|
|
PGF
|
placental growth factor
|
|
PGR
|
progesterone receptor
|
|
PGRMC1
|
progesterone receptor membrane component 1
|
|
PGRMC2
|
progesterone receptor membrane component 2
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLK1
|
polo-like kinase 1
|
|
PON1
|
paraoxonase 1
|
|
POSTN
|
periostin, osteoblast specific factor
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PROK1
|
prokineticin 1
|
|
PROM1
|
prominin 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGER3
|
prostaglandin E receptor 3 (subtype EP3)
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTP4A3
|
protein tyrosine phosphatase type IVA, member 3
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PVRL3
|
poliovirus receptor-related 3
|
|
PVRL4
|
poliovirus receptor-related 4
|
|
RB1
|
retinoblastoma 1
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RHOA
|
ras homolog family member A
|
|
RHOC
|
ras homolog family member C
|
|
RLN1
|
relaxin 1
|
|
ROCK2
|
Rho-associated, coiled-coil containing protein kinase 2
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
S100A4
|
S100 calcium binding protein A4
|
|
S100P
|
S100 calcium binding protein P
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SERPINF1
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1
|
|
SIRT1
|
sirtuin 1
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLIT2
|
slit homolog 2 (Drosophila)
|
|
SLIT3
|
slit homolog 3 (Drosophila)
|
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1)
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAR
|
steroidogenic acute regulatory protein
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STMN1
|
stathmin 1
|
|
STOML2
|
stomatin (EPB72)-like 2
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STX5
|
syntaxin 5
|
|
TACR1
|
tachykinin receptor 1
|
|
TAF1
|
TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa
|
|
TDGF1
|
teratocarcinoma-derived growth factor 1
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TERT
|
telomerase reverse transcriptase
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB1I1
|
transforming growth factor beta 1 induced transcript 1
|
|
THBS1
|
thrombospondin 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TLR3
|
toll-like receptor 3
|
|
TLR4
|
toll-like receptor 4
|
|
TMOD3
|
tropomodulin 3 (ubiquitous)
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF21
|
tumor necrosis factor receptor superfamily, member 21
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TP53
|
tumor protein p53
|
|
TPM3
|
tropomyosin 3
|
|
TRB
|
T cell receptor beta locus
|
|
TRO
|
trophinin
|
|
TRPV1
|
transient receptor potential cation channel, subfamily V, member 1
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TXN
|
thioredoxin
|
|
TXNIP
|
thioredoxin interacting protein
|
|
UCHL1
|
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)
|
|
UCN
|
urocortin
|
|
UCN2
|
urocortin 2
|
|
UCN3
|
urocortin 3
|
|
USF2
|
upstream transcription factor 2, c-fos interacting
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WNT4
|
wingless-type MMTV integration site family, member 4
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WT1
|
Wilms tumor 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YBX1
|
Y box binding protein 1
|
